What did ADCES 2026 reveal about the future of diabetes care? Explore key insights on AI, GLP-1 therapies, A1C monitoring, and digital engagement from this year’s conference.
Weight loss is not the only measure of success in obesity care. True progress includes metabolic health—such as A1C—and sustainable lifestyle changes beyond the scale
For Innovators & Clinicians: While GLP-1 agonists represent one of the most significant therapeutic breakthroughs in decades, their commercial and clinical potential is capped by a critical, unmet challenge: long-term
Orange Biomed exchanged key insights with industry experts while presenting our latest innovation at the 85th Scientific Sessions of the American Diabetes Association (ADA), held June 20-23, 2025, in Chicago.
Are you looking to navigate your own health and wellness journey? To support this goal, Orange Biomed sponsored a webinar featuring U.S. healthcare experts.
Hemoglobin A1C, Learn how it’s measured, its importance in diabetes management, factors affecting levels, & how to maintain healthy A1C for long-term health.
Join Orange Biomed at ADA Conference 2025 to explore OBM rapid A1c, a breakthrough in diabetes testing. Visit our booth for live demos and expert insights.
Stay informed about our launch and get exclusive updates straight to your inbox. Fill out the form below, and we’ll make sure you’re among the first to know when OBM rapid A1c test hits the market.